Schedule 13D ownership disclosure
ACADIA Pharmaceuticals Inc
Security class unavailable · CUSIP: 004225108
Event date: 2014-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 20,501,442
- Percent of class
- 20.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-037138
- Form type
- SC 13D
- Filer
- ACADIA PHARMACEUTICALS INC
- CIK
- CIK 1070494
- Filed
- Jun 12, 2014
- Reporting period
- Jun 06, 2014
- Description
- Schedule 13D beneficial ownership